Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in Metastatic Pancreatic Neuroendocrine Tumors
NCT02806648Phase 2Completed
- Sponsor
- Spanish Group of Neuroendocrine Tumors
- Start
- May 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in Pancreatic neuroendocrine tumor (PanNET), sponsored by Spanish Group of Neuroendocrine Tumors. Started May 2015; status: completed.
02
Drugs
palbociclib
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)
Beyond the preview
Go deeper on NCT02806648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806648.